{"library":[{"id":"addiction_federal_marketing","title":"42 CFR Part 2 confidentiality and FTC endorsement rules in addiction marketing (federal)","authority":"42 C.F.R. Part 2 (2024 Final Rule, effective Apr. 16, 2024, compliance required Feb. 16, 2026; OCR enforcement under the Aug. 25, 2025 delegation; civil and criminal penalties now apply; stricter than HIPAA for marketing uses). 16 C.F.R. Part 255 Endorsement Guides, 255.2 (typicality) and 255.5 (material connections). Enforced by HHS OCR and the FTC. 15 U.S.C. 45d (Opioid Addiction Recovery Fraud Prevention Act, 2018): unfair or deceptive acts or practices regarding any SUD treatment service or product are unlawful and treated as FTC rule violations, civil penalty up to $53,088 per violation (eff. Jan. 17, 2025).","jurisdiction":"US","status":"active","reviewed_date":"2026-07-23","review_interval_days":180,"status_detail":"","rule_counts":{"banned_claims":0,"required_disclaimers":1,"platform_policy_flags":0,"counsel_topics":0,"video_rules":0},"sources":[{"label":"42 C.F.R. Part 2 (eCFR current text)","url":"https://www.ecfr.gov/current/title-42/chapter-I/subchapter-A/part-2","primary":true},{"label":"16 C.F.R. Part 255 Endorsement Guides","url":"https://www.ecfr.gov/current/title-16/chapter-I/subchapter-B/part-255","primary":true},{"label":"HHS fact sheet, 42 CFR Part 2 Final Rule (2024)","url":"https://www.hhs.gov/hipaa/for-professionals/regulatory-initiatives/fact-sheet-42-cfr-part-2-final-rule/index.html","primary":false},{"label":"15 U.S.C. 45d (OARFPA 2018)","url":"https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title15-section45d&num=0&edition=prelim","primary":true}]},{"id":"addiction_platform_policies","title":"Platform certification requirements for addiction treatment advertising","authority":"Google Ads Healthcare and medicines policy (LegitScript certification required for addiction treatment advertisers since 2018). Meta advertising policies (2019: LegitScript certification plus written permission required). Microsoft Advertising and Nextdoor carry parallel requirements. Requirements cover treatment facilities AND lead generators and referral agencies. Certification timelines typically run 4 to 8 weeks.","jurisdiction":"US","status":"active","reviewed_date":"2026-07-23","review_interval_days":90,"status_detail":"","rule_counts":{"banned_claims":0,"required_disclaimers":0,"platform_policy_flags":1,"counsel_topics":0,"video_rules":0},"sources":[{"label":"Google Ads Healthcare and medicines policy","url":"https://support.google.com/adspolicy/answer/176031","primary":true},{"label":"Meta advertising standards, addiction treatment","url":"https://transparency.meta.com/policies/ad-standards/","primary":true},{"label":"LegitScript addiction treatment certification","url":"https://www.legitscript.com/service/certification/addiction-treatment/","primary":false}]},{"id":"arizona_addiction_marketing","title":"Arizona addiction treatment patient brokering and sober living home marketing (AZ)","authority":"A.R.S. 44-1522 (Arizona Consumer Fraud Act; unlawful deception, deceptive or unfair acts, false promise, misrepresentation, or concealment of a material fact in connection with the sale or advertisement of merchandise; enforced by the Arizona Attorney General and by private action). A.R.S. 13-3730 (Arizona patient-brokering and anti-kickback statute for sober living homes and substance use disorder treatment facilities; SB 1308, 2025; a tiered felony graded by the value exchanged, a class 3 felony at $1,000 or more, a class 4 felony above $100 and below $1,000, and a class 6 felony at $100 or less; no safe harbor in the statute's text). A.R.S. 36-2062 and 36-2063 (Arizona Department of Health Services sober living home licensure requirement and civil penalty of not more than $1,000 per day).","jurisdiction":"AZ","status":"active","reviewed_date":"2026-07-23","review_interval_days":90,"status_detail":"","rule_counts":{"banned_claims":4,"required_disclaimers":1,"platform_policy_flags":0,"counsel_topics":0,"video_rules":0},"sources":[{"label":"A.R.S. 44-1522 (Arizona Consumer Fraud Act, unlawful practices)","url":"https://www.azleg.gov/ars/44/01522.htm","primary":true},{"label":"A.R.S. 13-3730 (patient brokering; sober living homes and SUD treatment facilities)","url":"https://www.azleg.gov/ars/13/03730.htm","primary":true},{"label":"A.R.S. 36-2062 (sober living home licensure required)","url":"https://www.azleg.gov/ars/36/02062.htm","primary":true},{"label":"A.R.S. 36-2063 (sober living home civil penalty; ADHS)","url":"https://www.azleg.gov/ars/36/02063.htm","primary":true}]},{"id":"california_addiction_marketing","title":"California deceptive addiction treatment marketing and patient brokering (CA)","authority":"Cal. Health and Safety Code 11831.6 (SB 1228; no giving or receiving remuneration or anything of value for referral of a person seeking alcohol or other drug recovery or treatment services; covers licensed facilities, 10-percent-plus owners, employees, registered and certified counselors and licensed professionals, and certified programs and their workers; DHCS may implement via provider bulletins per subd. (b)). HSC 11831.7 (DHCS investigation and sanctions; AOD Code of Conduct (2019) sets a civil penalty up to $2,000 per occurrence plus license or certification suspension or revocation). HSC 11831.9 (SB 1165, amended Stats. 2024 ch. 847 eff. Jan. 1, 2025; false or misleading statements about products, goods, services, or geographical locations, medical treatments, or via deceptive websites). Cal. Bus. and Prof. Code 17500 (false advertising) and 17200 (Unfair Competition Law). Enforced by DHCS and the California Attorney General.","jurisdiction":"CA","status":"active","reviewed_date":"2026-07-23","review_interval_days":180,"status_detail":"","rule_counts":{"banned_claims":4,"required_disclaimers":1,"platform_policy_flags":0,"counsel_topics":0,"video_rules":0},"sources":[{"label":"Cal. HSC 11831.6 (referral remuneration)","url":"https://leginfo.legislature.ca.gov/faces/codes_displaySection.xhtml?sectionNum=11831.6&lawCode=HSC","primary":true},{"label":"Cal. HSC 11831.7 (DHCS enforcement)","url":"https://leginfo.legislature.ca.gov/faces/codes_displaySection.xhtml?sectionNum=11831.7&lawCode=HSC","primary":true},{"label":"Cal. HSC 11831.9 (false or misleading marketing; geographic locations)","url":"https://leginfo.legislature.ca.gov/faces/codes_displaySection.xhtml?sectionNum=11831.9&lawCode=HSC","primary":true},{"label":"Cal. Bus. and Prof. Code 17500 (false advertising)","url":"https://leginfo.legislature.ca.gov/faces/codes_displaySection.xhtml?sectionNum=17500&lawCode=BPC","primary":true},{"label":"Cal. Bus. and Prof. Code 17200 (UCL)","url":"https://leginfo.legislature.ca.gov/faces/codes_displaySection.xhtml?sectionNum=17200&lawCode=BPC","primary":true}]},{"id":"can_spam_email","title":"CAN-SPAM deceptive subject and sender (federal, email)","authority":"CAN-SPAM Act, 15 U.S.C. 7704(a)(1) (false or misleading transmission information) and 7704(a)(2) (deceptive subject headings); enforced by the FTC.","jurisdiction":"US","status":"active","reviewed_date":"2026-07-18","review_interval_days":365,"status_detail":"","rule_counts":{"banned_claims":7,"required_disclaimers":0,"platform_policy_flags":0,"counsel_topics":0,"video_rules":0},"sources":[{"label":"15 U.S.C. 7704 verbatim (govinfo.gov)","url":"https://www.govinfo.gov/content/pkg/USCODE-2022-title15/pdf/USCODE-2022-title15-chap103-sec7704.pdf","primary":true},{"label":"15 U.S.C. 7704 (official code viewer)","url":"https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title15-section7704&num=0&edition=prelim","primary":true},{"label":"FTC CAN-SPAM Act: A Compliance Guide for Business","url":"https://www.ftc.gov/business-guidance/resources/can-spam-act-compliance-guide-business","primary":true},{"label":"HubSpot: email footer addresses and unsubscribe (mechanical handling, out of scope here)","url":"https://knowledge.hubspot.com/marketing-email/edit-email-footer-addresses","primary":false},{"label":"HubSpot: subscription preferences and suppression","url":"https://knowledge.hubspot.com/records/manage-your-subscription-preferences-and-types","primary":false}]},{"id":"co_cannabis","title":"Colorado regulated marijuana signage and advertising (MED)","authority":"Colorado Marijuana Enforcement Division (Dept. of Revenue), Colorado Marijuana Rules 1 CCR 212-3, 3-700 Series (Signage and Advertising), Rules 3-705 through 3-755; C.R.S. 44-10-203(3)(a) (statutory advertising mandates).","jurisdiction":"CO","status":"pending_review","reviewed_date":null,"review_interval_days":180,"status_detail":"","rule_counts":{"banned_claims":5,"required_disclaimers":1,"platform_policy_flags":0,"counsel_topics":1,"video_rules":0},"sources":[{"label":"1 CCR 212-3 Colorado Marijuana Rules (official Secretary of State CCR PDF, current version)","url":"https://www.coloradosos.gov/CCR/GenerateRulePdf.do?ruleVersionId=12351&fileName=1+CCR+212-3","primary":true},{"label":"1 CCR 212-3 Rule 3-705 Advertising General Requirements (LII mirror, drift-check page)","url":"https://www.law.cornell.edu/regulations/colorado/1-CCR-212-3-3-705","primary":true},{"label":"C.R.S. 44-10-203 (state licensing authority rules, advertising mandates at (3)(a))","url":"https://colorado.public.law/statutes/crs_44-10-203","primary":false}]},{"id":"co_nmha_dora","title":"Colorado Natural Medicine advertising (NMHA / DNM)","authority":"CO Dept. of Revenue Natural Medicine Division, 1 CCR 213-1 Rule 3505 (Licensee Marketing); DORA Office of Natural Medicine Licensure, 4 CCR 755-1 Section 7 (Advertising); C.R.S. 12-170-105 and Title 44 Art. 50.","jurisdiction":"CO","status":"active","reviewed_date":"2026-07-18","review_interval_days":120,"status_detail":"","rule_counts":{"banned_claims":6,"required_disclaimers":0,"platform_policy_flags":0,"counsel_topics":4,"video_rules":0},"sources":[{"label":"1 CCR 213-1 (DOR Natural Medicine rules, Rule 3505 Licensee Marketing)","url":"https://www.coloradosos.gov/CCR/GenerateRulePdf.do?ruleVersionId=11634&fileName=1+CCR+213-1","primary":true},{"label":"4 CCR 755-1 Sec. 7 Advertising (facilitators)","url":"https://www.law.cornell.edu/regulations/colorado/4-CCR-755-1-7","primary":true},{"label":"C.R.S. 12-170-105 (advertising-standards mandate)","url":"https://law.justia.com/codes/colorado/title-12/business-professions-and-occupations/article-170/section-12-170-105/","primary":true},{"label":"C.R.S. 44-50-203 (DOR rulemaking authority)","url":"https://law.justia.com/codes/colorado/title-44/natural-medicine/article-50/part-2/section-44-50-203/","primary":true}]},{"id":"colorado_addiction_marketing","title":"Colorado deceptive addiction treatment marketing (CO)","authority":"Colorado Consumer Protection Act, C.R.S. 6-1-105 (deceptive trade practices, including false or misleading advertising) and 6-1-112 (civil penalty up to $20,000 per violation, per consumer or transaction; AG and district attorney enforcement plus private action). 2 CCR 502-1 (Behavioral Health Administration provider rules; SUD treatment providers must be licensed). C.R.S. 12-245-224(1)(q) (professional-discipline referral-remuneration prohibition WITH an express carve-out permitting licensees to pay independent advertising or marketing agents, including per-patient performance compensation). Enforced by the Colorado Attorney General and the Behavioral Health Administration.","jurisdiction":"CO","status":"active","reviewed_date":"2026-07-23","review_interval_days":180,"status_detail":"","rule_counts":{"banned_claims":4,"required_disclaimers":1,"platform_policy_flags":0,"counsel_topics":0,"video_rules":0},"sources":[{"label":"C.R.S. 6-1-105 (deceptive trade practices)","url":"https://leg.colorado.gov/sites/default/files/images/olls/crs2024-title-06.pdf","primary":true},{"label":"C.R.S. 6-1-112 (CCPA civil penalties)","url":"https://colorado.public.law/statutes/crs_6-1-112","primary":true},{"label":"C.R.S. 12-245-224(1)(q) (referral remuneration carve-out)","url":"https://leg.colorado.gov/","primary":true},{"label":"2 CCR 502-1 (BHA provider rules)","url":"https://bha.colorado.gov/for-service-providers/laws-and-rules","primary":false}]},{"id":"delaware_addiction_marketing","title":"Delaware deceptive addiction treatment marketing (DE)","authority":"Delaware patient-brokering law, 6 Del. C. 2502F (SB 32, 82 Del. Laws c. 202, signed 2019), a civil statute providing that a person may not engage in patient brokering, which reaches offering or paying, soliciting or receiving, and receiving the acceptance or acknowledgment of remuneration to induce a patient referral to a health-care provider or facility, and aiding or abetting that conduct, with a civil penalty up to $10,000 per violation under 6 Del. C. 2505F (a further $10,000 where the victim is an elder or disabled person, each willful day a separate violation) and no criminal grade. The statute is written for all of health care though enacted to target substance-use-disorder patient brokering. Delaware Consumer Fraud Act, 6 Del. C. 2513, supplies the general deceptive-marketing layer. Enforced as a civil matter by the State of Delaware.","jurisdiction":"DE","status":"active","reviewed_date":"2026-07-23","review_interval_days":180,"status_detail":"","rule_counts":{"banned_claims":4,"required_disclaimers":1,"platform_policy_flags":0,"counsel_topics":0,"video_rules":0},"sources":[{"label":"6 Del. C. Chapter 25F, Patient Brokering (2502F prohibition; 2505F civil penalty), SB 32 / 82 Del. Laws c. 202","url":"https://delcode.delaware.gov/title6/c025f/index.html","primary":true},{"label":"6 Del. C. 2513, Delaware Consumer Fraud Act (URL constructed by analogy to the delcode chapter path; verify on review)","url":"https://delcode.delaware.gov/title6/c025/index.html","primary":true}]},{"id":"ekra_referral_remuneration","title":"EKRA referral remuneration in marketing copy (federal, criminal)","authority":"Eliminating Kickbacks in Recovery Act, 18 U.S.C. 220. Criminal; applies to all payors including private insurance; covers remuneration for referrals to recovery homes, clinical treatment facilities, and laboratories; up to $200,000 and 10 years imprisonment per occurrence. Enforced by DOJ.","jurisdiction":"US","status":"active","reviewed_date":"2026-07-23","review_interval_days":180,"status_detail":"","rule_counts":{"banned_claims":1,"required_disclaimers":0,"platform_policy_flags":0,"counsel_topics":0,"video_rules":0},"sources":[{"label":"18 U.S.C. 220 (EKRA)","url":"https://www.law.cornell.edu/uscode/text/18/220","primary":true},{"label":"United States v. Schena, No. 23-2989 (9th Cir. 2025)","url":"https://cdn.ca9.uscourts.gov/datastore/opinions/2025/07/11/23-2989.pdf","primary":true},{"label":"DOJ press release, D.N.J. Sept. 15, 2020 guilty pleas","url":"https://www.justice.gov/usao-nj/pr","primary":false},{"label":"Tex. H&S Code 164.005 (solicitation compensation limits)","url":"https://statutes.capitol.texas.gov/Docs/HS/htm/HS.164.htm","primary":false},{"label":"N.Y. Mental Hygiene Law 32.06 (patient brokering, NY)","url":"https://www.nysenate.gov/legislation/laws/MHY/32.06","primary":false},{"label":"Cal. HSC 11831.6 (referral remuneration, CA)","url":"https://leginfo.legislature.ca.gov/faces/codes_displaySection.xhtml?sectionNum=11831.6&lawCode=HSC","primary":false},{"label":"C.R.S. 12-245-224(1)(q) (CO marketing-agent carve-out)","url":"https://leg.colorado.gov/","primary":false}]},{"id":"fl_dental","title":"Florida dental advertising (Board of Dentistry)","authority":"Florida Board of Dentistry, Rule 64B5-4.002 F.A.C. (Advertising and Soliciting by Dentists, amended eff. 2026-04-26) and Rule 64B5-4.003 F.A.C. (Advertisement of Fees and Discounted Services). Statutes: Fla. Stat. 466.019 (Advertising by dentists, as amended by ch. 2024-214), 466.0282 (Specialties), 466.028(1)(d), (jj) (discipline), 456.062 (free/discounted-service advertising statement).","jurisdiction":"FL","status":"pending_review","reviewed_date":null,"review_interval_days":180,"status_detail":"","rule_counts":{"banned_claims":8,"required_disclaimers":5,"platform_policy_flags":0,"counsel_topics":2,"video_rules":0},"sources":[{"label":"Fla. Stat. 466.019 (Advertising by dentists, 2025 statutes)","url":"https://www.flsenate.gov/Laws/Statutes/2025/466.019","primary":true},{"label":"Fla. Stat. 466.0282 (Specialties)","url":"https://www.flsenate.gov/Laws/Statutes/2025/466.0282","primary":true},{"label":"Fla. Stat. 466.028 (Grounds for disciplinary action; (1)(d), (1)(jj))","url":"https://www.flsenate.gov/Laws/Statutes/2025/466.028","primary":true},{"label":"Fla. Stat. 456.062 (Advertisement of free or discounted services; required statement)","url":"https://www.leg.state.fl.us/statutes/index.cfm?App_mode=Display_Statute&URL=0400-0499/0456/Sections/0456.062.html","primary":true},{"label":"Rule 64B5-4.002 F.A.C. (Advertising and Soliciting by Dentists; rule page, eff. 2026-04-26)","url":"https://flrules.org/gateway/ruleno.asp?id=64B5-4.002&Section=0","primary":true},{"label":"Rule 64B5-4.002 amendment notice ((3)(h) disclaimer text)","url":"https://www.flrules.org/gateway/readFile.asp?sid=1&tid=7673493&type=1&File=64B5-4.002.htm","primary":true},{"label":"Chapter 64B5-4 F.A.C. rule listing (64B5-4.004 and 64B5-4.005 repealed)","url":"https://flrules.org/gateway/ChapterHome.asp?Chapter=64B5-4","primary":true},{"label":"Rule 64B5-4.002 full text through 2-26-06 (Cornell LII cross-check)","url":"https://www.law.cornell.edu/regulations/florida/Fla-Admin-Code-Ann-R-64B5-4-002","primary":false},{"label":"Rule 64B5-4.003 F.A.C. (Advertisement of Fees and Discounted Services, Cornell LII)","url":"https://www.law.cornell.edu/regulations/florida/Fla-Admin-Code-Ann-R-64B5-4-003","primary":false}]},{"id":"fl_medical_marijuana","title":"Florida MMTC advertising and marketing (DOH approval regime)","authority":"Fla. Stat. 381.986(8)(h) (2025) (MMTC advertising; department approval; public-visibility ban); Florida Department of Health Emergency Rule 64ER25-6, MMTC Advertising and Marketing, effective 12-31-2025; Office of Medical Marijuana Use.","jurisdiction":"FL","status":"pending_review","reviewed_date":null,"review_interval_days":180,"status_detail":"","rule_counts":{"banned_claims":6,"required_disclaimers":2,"platform_policy_flags":0,"counsel_topics":1,"video_rules":0},"sources":[{"label":"Fla. Stat. 381.986 (2025), medical use of marijuana (subsection (8)(h) advertising)","url":"https://www.flsenate.gov/Laws/Statutes/2025/381.986","primary":true},{"label":"Florida DOH Emergency Rule 64ER25-6, MMTC Advertising and Marketing (flrules.org rule page, eff. 12-31-2025)","url":"https://www.flrules.org/gateway/ruleNo.asp?id=64ER25-6","primary":true},{"label":"64ER25-6 full rule text (flrules.org document download)","url":"https://www.flrules.org/gateway/readFile.asp?sid=0&tid=30373142&type=1&file=64ER25-6.doc","primary":true},{"label":"Office of Medical Marijuana Use, rules and regulations page (rule and form postings)","url":"https://knowthefactsmmj.com/rules-and-regulations/","primary":true}]},{"id":"florida_addiction_marketing","title":"Florida deceptive addiction treatment marketing and patient brokering (FL)","authority":"Fla. Stat. 397.55 (deceptive marketing prohibition; (1)(c) routes violations to the criminal Patient Brokering Act; other violations are first-degree misdemeanors). Fla. Stat. 817.505 (Patient Brokering Act, criminal; penalty tiers at (4): third-degree felony and $50,000 fine at baseline, second-degree felony and $100,000 for 10 to 19 patients, first-degree felony and $500,000 for 20 or more patients; information-services exception at (3)(i)). Enforced by the Florida Attorney General and state prosecutors.","jurisdiction":"FL","status":"active","reviewed_date":"2026-07-23","review_interval_days":180,"status_detail":"","rule_counts":{"banned_claims":4,"required_disclaimers":1,"platform_policy_flags":0,"counsel_topics":0,"video_rules":0},"sources":[{"label":"Fla. Stat. 397.55","url":"https://www.leg.state.fl.us/statutes/index.cfm?App_mode=Display_Statute&URL=0300-0399/0397/Sections/0397.55.html","primary":true},{"label":"Fla. Stat. 817.505 (Patient Brokering Act)","url":"https://www.leg.state.fl.us/statutes/index.cfm?App_mode=Display_Statute&URL=0800-0899/0817/Sections/0817.505.html","primary":true},{"label":"Fla. Stat. 501.605 (Telemarketing Act licensure)","url":"https://www.leg.state.fl.us/statutes/index.cfm?App_mode=Display_Statute&URL=0500-0599/0501/Sections/0501.605.html","primary":true},{"label":"FAC 5J-6.005 (Substance Abuse Marketing Service Provider license)","url":"https://www.flrules.org/gateway/RuleNo.asp?title=TELEMARKETING&ID=5J-6.005","primary":false}]},{"id":"florida_ketamine","title":"Florida Board of Medicine advertising (physician-supervised care)","authority":"Florida Board of Medicine, Rule 64B8-11.001 F.A.C. (Advertising); Fla. Stat. 458.331, 456.062, 458.3312. DO-run clinics: Board of Osteopathic Medicine, Rule 64B15-14.001.","jurisdiction":"FL","status":"active","reviewed_date":"2026-07-23","review_interval_days":180,"status_detail":"Two Florida attorney-queue items (the 2026-03 amendment and the 458.331(1)(rr) question) relayed as cleared by the operator (2026-07-19), not yet backed by a dated counsel artifact. Client approval still required.","rule_counts":{"banned_claims":5,"required_disclaimers":2,"platform_policy_flags":0,"counsel_topics":5,"video_rules":0},"sources":[{"label":"Rule 64B8-11.001 F.A.C. (Board of Medicine advertising)","url":"https://flrules.org/gateway/ruleno.asp?id=64B8-11.001","primary":true},{"label":"Rule 64B8-11.001 verbatim text (Cornell LII, through 2020)","url":"https://www.law.cornell.edu/regulations/florida/Fla-Admin-Code-Ann-R-64B8-11-001","primary":false},{"label":"Rule 64B15-14.001 F.A.C. (Board of Osteopathic Medicine advertising)","url":"https://flrules.org/gateway/ruleno.asp?id=64B15-14.001","primary":true},{"label":"Fla. Stat. 458.331 (grounds for discipline)","url":"https://www.leg.state.fl.us/statutes/index.cfm?App_mode=Display_Statute&URL=0400-0499/0458/Sections/0458.331.html","primary":true},{"label":"Fla. Stat. 456.062 (advertising of free or discounted services)","url":"https://www.leg.state.fl.us/statutes/index.cfm?App_mode=Display_Statute&URL=0400-0499/0456/Sections/0456.062.html","primary":true}]},{"id":"ftc_health_claims","title":"FTC deceptive health claims and endorsements (federal, always-on)","authority":"FTC Act Section 5 (15 U.S.C. 45, unfair or deceptive acts) and Section 12 (15 U.S.C. 52, false advertising of food, drugs, devices, services, cosmetics); FTC Health Products Compliance Guidance (Dec. 2022); 16 CFR Part 255 Endorsement Guides (2023 revision); 16 CFR 251.1 (use of the word Free). Enforced by the FTC.","jurisdiction":"US","status":"active","reviewed_date":"2026-07-23","review_interval_days":180,"status_detail":"","rule_counts":{"banned_claims":8,"required_disclaimers":3,"platform_policy_flags":0,"counsel_topics":2,"video_rules":0},"sources":[{"label":"15 U.S.C. 45 (FTC Act Section 5, official code viewer)","url":"https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title15-section45&num=0&edition=prelim","primary":true},{"label":"15 U.S.C. 52 (FTC Act Section 12, false advertisements, official code viewer)","url":"https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title15-section52&num=0&edition=prelim","primary":true},{"label":"FTC Health Products Compliance Guidance (Dec. 2022)","url":"https://www.ftc.gov/business-guidance/resources/health-products-compliance-guidance","primary":true},{"label":"16 CFR Part 255 Endorsement Guides, 2023 revision (Cornell LII mirror; ecfr.gov bot-blocked at authoring)","url":"https://www.law.cornell.edu/cfr/text/16/part-255","primary":false},{"label":"16 CFR 255.2 Consumer endorsements (Cornell LII mirror)","url":"https://www.law.cornell.edu/cfr/text/16/255.2","primary":false},{"label":"16 CFR 255.5 Disclosure of material connections (Cornell LII mirror)","url":"https://www.law.cornell.edu/cfr/text/16/255.5","primary":false},{"label":"16 CFR 251.1 Guide concerning use of the word Free (Cornell LII mirror)","url":"https://www.law.cornell.edu/cfr/text/16/251.1","primary":false},{"label":"FTC's Endorsement Guides: What People Are Asking (FAQ)","url":"https://www.ftc.gov/business-guidance/resources/ftcs-endorsement-guides-what-people-are-asking","primary":true}]},{"id":"ftc_video_disclosures","title":"FTC clear-and-conspicuous disclosure in video (federal, video assets)","authority":"FTC Act Section 5 (15 U.S.C. 45); FTC .com Disclosures: How to Make Effective Disclosures in Digital Advertising (Mar. 2013), duration and proximity factors; FTC Health Products Compliance Guidance (Dec. 2022), disclosure adequacy; 16 CFR Part 255 Endorsement Guides (2023 revision), 255.1(b) and 255.2(b). Enforced by the FTC.","jurisdiction":"US","status":"active","reviewed_date":"2026-07-23","review_interval_days":365,"status_detail":"","rule_counts":{"banned_claims":0,"required_disclaimers":0,"platform_policy_flags":0,"counsel_topics":0,"video_rules":5},"sources":[{"label":"FTC .com Disclosures: How to Make Effective Disclosures in Digital Advertising (2013)","url":"https://www.ftc.gov/business-guidance/resources/com-disclosures-how-make-effective-disclosures-digital-advertising","primary":true},{"label":"FTC Health Products Compliance Guidance (2022)","url":"https://www.ftc.gov/business-guidance/resources/health-products-compliance-guidance","primary":true},{"label":"16 CFR Part 255, Guides Concerning the Use of Endorsements and Testimonials (2023 revision)","url":"https://www.ecfr.gov/current/title-16/chapter-I/subchapter-B/part-255","primary":true}]},{"id":"georgia_addiction_marketing","title":"Georgia deceptive addiction treatment marketing (GA)","authority":"Georgia patient brokering law, O.C.G.A. 26-5-80 (SB 4, 2021, effective July 1, 2021), prohibiting remuneration for substance-use-disorder patient referrals, tiered by patient count (a misdemeanor when the conduct involves fewer than ten patients; a felony at ten or more, up to a $500,000 fine per violation at twenty or more). Georgia Fair Business Practices Act, O.C.G.A. 10-1-390 et seq., core prohibition at 10-1-393(a), interpreted consistently with FTC Act Section 5. O.C.G.A. 26-5-80(c) sets AKS-style safe harbors, including an information-service exemption at (c)(8) conditioned on non-steering, no promises of cure or guarantees of treatment, no transportation, and fair-market fees not based on patient value. Enforced by the Georgia Attorney General.","jurisdiction":"GA","status":"active","reviewed_date":"2026-07-23","review_interval_days":180,"status_detail":"","rule_counts":{"banned_claims":4,"required_disclaimers":1,"platform_policy_flags":0,"counsel_topics":0,"video_rules":0},"sources":[{"label":"O.C.G.A. 26-5-80 (Prohibition on Patient Brokering), SB 4 (2021) signed text","url":"https://gov.georgia.gov/document/2021-signed-legislation/sb-4/download","primary":true},{"label":"O.C.G.A. 10-1-393 (Fair Business Practices Act, unlawful acts)","url":"https://consumer.georgia.gov/consumer-topics/fair-business-practices-act","primary":true},{"label":"Georgia General Assembly SB 4 (2021) bill page","url":"https://www.legis.ga.gov/legislation/58874","primary":true}]},{"id":"hipaa_marketing","title":"HIPAA marketing rule (federal)","authority":"45 CFR 164.501 and 164.508(a)(3)-(4); HHS Office for Civil Rights. 2013 Omnibus (HITECH) final rule.","jurisdiction":"US","status":"active","reviewed_date":"2026-07-23","review_interval_days":365,"status_detail":"","rule_counts":{"banned_claims":1,"required_disclaimers":0,"platform_policy_flags":0,"counsel_topics":2,"video_rules":0},"sources":[{"label":"45 CFR 164.501 (definition of Marketing and Financial remuneration)","url":"https://www.govinfo.gov/content/pkg/CFR-2023-title45-vol2/pdf/CFR-2023-title45-vol2-sec164-501.pdf","primary":true},{"label":"45 CFR 164.508(a)(3)-(4) (authorization for marketing and sale of PHI)","url":"https://www.govinfo.gov/content/pkg/CFR-2023-title45-vol2/pdf/CFR-2023-title45-vol2-sec164-508.pdf","primary":true},{"label":"HHS OCR Marketing guidance","url":"https://www.hhs.gov/sites/default/files/ocr/privacy/hipaa/understanding/coveredentities/marketing.pdf","primary":true},{"label":"Cornell LII 45 CFR 164.501 (cross-check)","url":"https://www.law.cornell.edu/cfr/text/45/164.501","primary":false}]},{"id":"louisiana_addiction_marketing","title":"Louisiana addiction treatment marketing (LA)","authority":"Louisiana Unfair Trade Practices and Consumer Protection Law, La. R.S. 51:1405(A) (unfair or deceptive acts or practices in trade or commerce declared unlawful; Louisiana Attorney General enforcement plus a private right of action), together with La. R.S. 14:70.5.1 (Act 312 of 2026, HB676, signed May 22 2026), a criminal-only prohibition barring any person from knowingly or intentionally soliciting, offering, paying, or receiving any fee, payment, rebate, commission, or anything of value for the referral of a patient to a residential substance abuse facility, a mental health facility, or a facility licensed for substance use disorder treatment, or urging or marketing the same, with a safe harbor at subsection (B) for fees under a lawful agreement that do not vary by number of patients, duration, level, volume, or nature of services; punishable by imprisonment with or without hard labor up to five years, a fine up to $50,000, or both, plus restitution under C.Cr.P. 883.2. Enforced by Louisiana district attorneys (criminal) and the Louisiana Attorney General (LUTPA).","jurisdiction":"LA","status":"active","reviewed_date":"2026-07-23","review_interval_days":90,"status_detail":"","rule_counts":{"banned_claims":4,"required_disclaimers":1,"platform_policy_flags":0,"counsel_topics":0,"video_rules":0},"sources":[{"label":"La. R.S. 14:70.5.1 (Act 312 of 2026, HB676), enrolled text","url":"https://www.legis.la.gov/Legis/ViewDocument.aspx?d=1473982","primary":true},{"label":"La. R.S. 51:1405(A) (Louisiana Unfair Trade Practices and Consumer Protection Law)","url":"https://www.legis.la.gov/","primary":true}]},{"id":"new_jersey_addiction_marketing","title":"New Jersey addiction treatment patient brokering and deceptive marketing (NJ)","authority":"N.J.S.A. 2C:40A-6 (patient brokering, as amended by P.L. 2025 c.121 / A3973, signed and effective Aug 11 2025; a third-degree crime carrying a fixed $50,000 criminal fine plus restitution, and a civil penalty up to $20,000 per violation). N.J.S.A. 56:8-230 to 56:8-232 (deceptive substance use disorder treatment marketing, P.L. 2025 c.122 / A3974, six enumerated unlawful practices; civil penalty up to $20,000 per violation under the Penalty Enforcement Law, plus a private right of action and treble damages under the Consumer Fraud Act family). Enforced by the Department of Health as to licensed treatment facilities and clinical laboratories, and by the Division of Consumer Affairs as to recovery residences.","jurisdiction":"NJ","status":"active","reviewed_date":"2026-07-23","review_interval_days":120,"status_detail":"","rule_counts":{"banned_claims":6,"required_disclaimers":1,"platform_policy_flags":0,"counsel_topics":0,"video_rules":0},"sources":[{"label":"N.J.S.A. 2C:40A-6 (patient brokering, P.L. 2025 c.121 / A3973)","url":"https://pub.njleg.gov/Bills/2024/AL25/121_.HTM","primary":true},{"label":"N.J.S.A. 56:8-230 to 56:8-232 (deceptive substance use disorder treatment marketing, P.L. 2025 c.122 / A3974)","url":"https://pub.njleg.gov/Bills/2024/AL25/122_.HTM","primary":true}]},{"id":"new_mexico_addiction_marketing","title":"New Mexico deceptive addiction treatment marketing (NM)","authority":"New Mexico Unfair Practices Act, NMSA 57-12-2(D) (unfair or deceptive trade practices: false or misleading statements KNOWINGLY made in connection with the sale of services) and 57-12-3 (declaring such practices unlawful), enforced by the Attorney General with a civil penalty up to $5,000 per willful violation (57-12-11) and a private treble-damages action for willful violations (57-12-10). Advertising is expressly within trade or commerce under the Act. NMAC Title 7, Chapter 21 (behavioral health provider certification). Enforced by the New Mexico Attorney General and the Health Care Authority behavioral health division.","jurisdiction":"NM","status":"active","reviewed_date":"2026-07-23","review_interval_days":180,"status_detail":"","rule_counts":{"banned_claims":4,"required_disclaimers":1,"platform_policy_flags":0,"counsel_topics":0,"video_rules":0},"sources":[{"label":"NMSA 57-12-2 (unfair or deceptive practices)","url":"https://law.justia.com/codes/new-mexico/chapter-57/article-12/section-57-12-2/","primary":true},{"label":"NMSA 57-12-3 (unlawful)","url":"https://law.justia.com/codes/new-mexico/chapter-57/article-12/","primary":true},{"label":"NMSA 57-12-10 (private treble damages)","url":"https://law.justia.com/codes/new-mexico/chapter-57/article-12/section-57-12-10/","primary":true},{"label":"NMSA 57-12-11 (civil penalty)","url":"https://law.justia.com/codes/new-mexico/chapter-57/article-12/","primary":true},{"label":"NMAC 7.21 (behavioral health)","url":"https://www.srca.nm.gov/parts/title07/07.021.0001.html","primary":false}]},{"id":"new_mexico_psilocybin","title":"New Mexico medical psilocybin (no adopted advertising rules)","authority":"New Mexico Medical Psilocybin Act, SB 219 (2025); NM Department of Health, Center for Medical Cannabis and Psilocybin. No advertising or marketing rule adopted or proposed.","jurisdiction":"NM","status":"not_yet_regulated","reviewed_date":null,"review_interval_days":null,"status_detail":"NO ADOPTED ADVERTISING RULES AS OF 2026-07-18","rule_counts":{"banned_claims":0,"required_disclaimers":0,"platform_policy_flags":0,"counsel_topics":0,"video_rules":0},"sources":[{"label":"New Mexico SB 219, Medical Psilocybin Act (2025) full text","url":"https://www.nmlegis.gov/Sessions/25%20Regular/bills/senate/SB0219.HTML","primary":true},{"label":"NM DOH Medical Psilocybin Program","url":"https://www.nmhealth.org/about/mcpp/mpp/","primary":true},{"label":"NM DOH Rules and Regulations (Title 7 Ch. 35 rulemaking list)","url":"https://www.nmhealth.org/about/asd/cmo/rules","primary":true}]},{"id":"new_york_addiction_marketing","title":"New York deceptive addiction treatment marketing and patient brokering (NY)","authority":"N.Y. Mental Hygiene Law 32.06 (patient-brokering prohibition, both directions; provider includes any entity providing or PURPORTING TO PROVIDE substance use disorder services or operating a certified recovery residence; intentional violation of subdivision 2 or 3 is a misdemeanor as defined in the penal law). N.Y. MHL 32.05 (no SUD services without Commissioner approval or an operating certificate) and 32.21 (fines, suspension, revocation). OASAS Local Services Bulletin, Limitations and Prohibitions on Programs and Practitioners (Aug. 4, 2017). N.Y. General Business Law 349 (deceptive acts, AG enforcement plus private action under 349(h)) and 350 (false advertising). Enforced by OASAS and the New York Attorney General.","jurisdiction":"NY","status":"active","reviewed_date":"2026-07-23","review_interval_days":180,"status_detail":"","rule_counts":{"banned_claims":4,"required_disclaimers":1,"platform_policy_flags":0,"counsel_topics":0,"video_rules":0},"sources":[{"label":"N.Y. Mental Hygiene Law 32.06 (patient brokering)","url":"https://www.nysenate.gov/legislation/laws/MHY/32.06","primary":true},{"label":"N.Y. Mental Hygiene Law 32.05 (operating certificate)","url":"https://www.nysenate.gov/legislation/laws/MHY/32.05","primary":true},{"label":"N.Y. Mental Hygiene Law 32.21 (fines, suspension, revocation)","url":"https://www.nysenate.gov/legislation/laws/MHY/32.21","primary":true},{"label":"OASAS Local Services Bulletin, Limitations and Prohibitions on Programs and Practitioners (Aug. 4, 2017)","url":"https://oasas.ny.gov/legal","primary":false},{"label":"N.Y. General Business Law 349 (deceptive acts)","url":"https://www.nysenate.gov/legislation/laws/GBS/349","primary":true},{"label":"N.Y. General Business Law 350 (false advertising)","url":"https://www.nysenate.gov/legislation/laws/GBS/350","primary":true}]},{"id":"nm_cannabis","title":"New Mexico cannabis advertising and marketing (CCD)","authority":"New Mexico Cannabis Regulation Act, NMSA 1978 Section 26-2C-20 (advertising and marketing restrictions, eff. June 29, 2021); 16.8.3.8 NMAC (Advertising and Marketing, eff. 04/01/2022), Cannabis Control Division, Regulation and Licensing Department.","jurisdiction":"NM","status":"pending_review","reviewed_date":null,"review_interval_days":180,"status_detail":"","rule_counts":{"banned_claims":6,"required_disclaimers":6,"platform_policy_flags":0,"counsel_topics":1,"video_rules":0},"sources":[{"label":"16.8.3 NMAC, Packaging, Labeling, Advertising, Marketing, and Commercial Display Requirements (official NM State Records Center and Archives text)","url":"https://www.srca.nm.gov/parts/title16/16.008.0003.html","primary":true},{"label":"NMSA 1978 Chapter 26 Article 2C, Cannabis Regulation Act (RLD-hosted compilation; Section 26-2C-20 advertising and marketing restrictions)","url":"https://www.rld.nm.gov/wp-content/uploads/2023/08/ARTICLE-2C-Cannabis-Regulation-_-Chapter-26-Drugs-and-Cosmetics.pdf","primary":true}]},{"id":"north_carolina_addiction_marketing","title":"North Carolina addiction treatment patient brokering and deceptive marketing (NC)","authority":"N.C. Gen. Stat. Chapter 90, Article 5H (Substance Use Disorder Facilities and Recovery Residences, the SAFE Act, S.L. 2023-141, effective January 1, 2024). Patient brokering at 90-113.152 (a Class G felony, with each violation a separate offense; exemptions at (b) for a federal Anti-Kickback safe harbor under 42 U.S.C. 1320a-7b(b)(3) and a reasonable contingency-management incentive). Deceptive marketing at 90-113.151 (Truth in Marketing; a Class G felony under (c) and (d), and an unfair or deceptive trade practice under N.C. Gen. Stat. 75-1.1 via (e)). Referral defined at 90-113.150(3). Enforced through North Carolina criminal prosecution, the Attorney General under Chapter 75, and Department of Health and Human Services licensure oversight.","jurisdiction":"NC","status":"active","reviewed_date":"2026-07-23","review_interval_days":150,"status_detail":"","rule_counts":{"banned_claims":5,"required_disclaimers":1,"platform_policy_flags":0,"counsel_topics":0,"video_rules":0},"sources":[{"label":"N.C. Gen. Stat. Chapter 90, Article 5H (SAFE Act; 90-113.150 definitions, 90-113.151 Truth in Marketing, 90-113.152 patient brokering)","url":"https://www.ncleg.gov/EnactedLegislation/Statutes/HTML/ByArticle/Chapter_90/Article_5H.html","primary":true}]},{"id":"ny_cannabis","title":"New York adult-use cannabis marketing and advertising","authority":"NY Cannabis Law Article 4 Section 86 (advertising and marketing restrictions); 9 NYCRR Part 129 (Adult-Use Marketing and Advertising) with Part 128 definitions, revised regulations adopted per CCB Resolution 2025-81 and filed for State Register publication December 3, 2025; Office of Cannabis Management.","jurisdiction":"NY","status":"pending_review","reviewed_date":null,"review_interval_days":120,"status_detail":"","rule_counts":{"banned_claims":7,"required_disclaimers":4,"platform_policy_flags":0,"counsel_topics":1,"video_rules":0},"sources":[{"label":"9 NYCRR Parts 128 and 129, revised adopted PLMA regulations (official OCM PDF, in effect)","url":"https://cannabis.ny.gov/adopted-plma-regulations","primary":true},{"label":"OCM release, December 12, 2025: revised PLMA regulations filed December 3, 2025 and in effect","url":"https://cannabis.ny.gov/plma-regulations-update-release","primary":true},{"label":"NY Cannabis Law Section 86 (restrictions on cannabis-related advertising and marketing)","url":"https://www.nysenate.gov/legislation/laws/CAN/86","primary":true}]},{"id":"ny_professional_advertising","title":"New York professional advertising (Regents Part 29 and Education Law 6530)","authority":"NY Board of Regents rules on unprofessional conduct, 8 NYCRR 29.1(b)(12), 29.1(b)(2), 29.2 (NYSED Office of the Professions); for physicians, NY Education Law 6530(17), (27), (34), enforced by the Board for Professional Medical Conduct under Public Health Law 230.","jurisdiction":"NY","status":"pending_review","reviewed_date":null,"review_interval_days":180,"status_detail":"","rule_counts":{"banned_claims":9,"required_disclaimers":3,"platform_policy_flags":0,"counsel_topics":3,"video_rules":0},"sources":[{"label":"NYSED Office of the Professions, Rules of the Board of Regents, Part 29 (Unprofessional Conduct)","url":"https://www.op.nysed.gov/title8/rules-board-regents/part-29","primary":true},{"label":"NY Education Law 6530 (definitions of professional misconduct, physicians), NY Senate official text","url":"https://www.nysenate.gov/legislation/laws/EDN/6530","primary":true},{"label":"NY Public Health Law 230 (Board for Professional Medical Conduct), NY Senate official text","url":"https://www.nysenate.gov/legislation/laws/PBH/230","primary":true},{"label":"8 NYCRR 29.1 (general provisions, all professions), Cornell LII","url":"https://www.law.cornell.edu/regulations/new-york/8-NYCRR-29.1","primary":false},{"label":"8 NYCRR 29.2 (general provisions for health professions), Cornell LII","url":"https://www.law.cornell.edu/regulations/new-york/8-NYCRR-29.2","primary":false},{"label":"NY Education Law 6530, FindLaw mirror (sub-clause cross-check)","url":"https://codes.findlaw.com/ny/education-law/edn-sect-6530/","primary":false},{"label":"NY Education Law 6530, public.law mirror (subdivision numbering cross-check)","url":"https://newyork.public.law/laws/n.y._education_law_section_6530","primary":false}]},{"id":"ohio_addiction_marketing","title":"Ohio addiction treatment marketing (recovery-housing referral advisory; HB 58 watch)","authority":"Ohio R.C. 5119.396 (prohibition against referrals to non-registry recovery housing residences, in force, operative Jan. 1, 2025) and R.C. 5119.394 (OMHAS registry of recovery housing residences). WATCH: Ohio HB 58 (136th General Assembly), which would add a certificate-of-need program for recovery housing and criminalize compensation for patient referrals, passed the House 92-0 on Feb. 25, 2026 and is pending in the Senate; it is not yet law and is not compiled here.","jurisdiction":"OH","status":"active","reviewed_date":"2026-07-23","review_interval_days":90,"status_detail":"ONE ENACTED REFERRAL ADVISORY IN FORCE; HB 58 PENDING (WATCH)","rule_counts":{"banned_claims":0,"required_disclaimers":0,"platform_policy_flags":0,"counsel_topics":0,"video_rules":0},"sources":[{"label":"Ohio R.C. 5119.396 (prohibition against referrals to non-registry recovery residences)","url":"https://codes.ohio.gov/ohio-revised-code/section-5119.396","primary":true},{"label":"Ohio R.C. 5119.394 (OMHAS registry of recovery housing residences)","url":"https://codes.ohio.gov/ohio-revised-code/section-5119.394","primary":true},{"label":"Ohio HB 58 (136th General Assembly), House-passed 2026-02-25, pending Senate","url":"https://www.legislature.ohio.gov/legislation/136/hb58","primary":true}]},{"id":"or_cannabis","title":"Oregon OLCC marijuana advertising","authority":"Oregon Liquor and Cannabis Commission: OAR 845-025-8000 to 845-025-8080 (advertising rules; esp. 845-025-8040 Advertising Restrictions), 845-025-8520(9) (marijuana as a prize), 845-025-8540(2)(a)(D) (curative/therapeutic misrepresentation); enabling statute ORS 475C.017(2)(e).","jurisdiction":"OR","status":"pending_review","reviewed_date":null,"review_interval_days":180,"status_detail":"","rule_counts":{"banned_claims":7,"required_disclaimers":3,"platform_policy_flags":1,"counsel_topics":1,"video_rules":0},"sources":[{"label":"OAR chapter 845 division 25, Recreational Marijuana (current rules, Oregon SOS)","url":"https://secure.sos.state.or.us/oard/displayDivisionRules.action?selectedDivision=3873","primary":true},{"label":"OAR 845-025-8040 Advertising Restrictions (single-rule page, Oregon SOS)","url":"https://secure.sos.state.or.us/oard/viewSingleRule.action?ruleVrsnRsn=239093","primary":true},{"label":"OLCC Cannabis Laws and Rules","url":"https://www.oregon.gov/olcc/marijuana/Pages/Recreational-Marijuana-Laws-and-Rules.aspx","primary":true},{"label":"ORS chapter 475C, Cannabis Regulation (2025 edition, Oregon Legislature)","url":"https://www.oregonlegislature.gov/bills_laws/ors/ors475c.html","primary":true},{"label":"ORS 475C.017 (OLCC general powers and duties; advertising rulemaking authority at (2)(e))","url":"https://oregon.public.law/statutes/ors_475c.017","primary":false},{"label":"Google Ads Dangerous products or services policy","url":"https://support.google.com/adspolicy/answer/6014299","primary":true},{"label":"Meta Advertising Standards, Drugs and Pharmaceuticals","url":"https://transparency.meta.com/policies/ad-standards/restricted-goods-services/drugs-pharmaceuticals/","primary":true}]},{"id":"or_psilocybin","title":"Oregon Psilocybin Services advertising (OHA)","authority":"Oregon Health Authority, Oregon Psilocybin Services: OAR 333-333-6100 (Advertising Restrictions), 333-333-6110 (Advertising Media, Coupons, and Promotions), 333-333-6120 (Removal of Objectionable and Non-Conforming Advertising), 333-333-6040(2)(c) (Dishonest Conduct), 333-333-4480(5)(a) (no product discounts or free product); enabling statute ORS 475A.235(2)(e)-(f).","jurisdiction":"OR","status":"pending_review","reviewed_date":null,"review_interval_days":120,"status_detail":"","rule_counts":{"banned_claims":7,"required_disclaimers":0,"platform_policy_flags":1,"counsel_topics":3,"video_rules":0},"sources":[{"label":"OAR chapter 333 division 333, Oregon Psilocybin Services (current rules, Oregon SOS)","url":"https://secure.sos.state.or.us/oard/displayDivisionRules.action?selectedDivision=7102","primary":true},{"label":"OHA Oregon Psilocybin Services, Administrative Rules and Rulemaking Process","url":"https://www.oregon.gov/oha/ph/preventionwellness/pages/psilocybin-administrative-rules.aspx","primary":true},{"label":"ORS chapter 475A, Psilocybin Regulation (2025 edition, Oregon Legislature)","url":"https://www.oregonlegislature.gov/bills_laws/ors/ors475a.html","primary":true},{"label":"ORS 475A.235 (OHA general powers and duties; advertising rulemaking authority)","url":"https://oregon.public.law/statutes/ors_475a.235","primary":false},{"label":"Google Ads Dangerous products or services policy","url":"https://support.google.com/adspolicy/answer/6014299","primary":true},{"label":"Meta Advertising Standards, Drugs and Pharmaceuticals","url":"https://transparency.meta.com/policies/ad-standards/restricted-goods-services/drugs-pharmaceuticals/","primary":true}]},{"id":"oregon_addiction_marketing","title":"Oregon deceptive addiction treatment marketing (OR)","authority":"Oregon Unlawful Trade Practices Act, ORS 646.608 (unlawful trade practices, including false or misleading representations about services), 646.642 (civil penalty up to $25,000 per willful violation), and 646.638 (private action, actual damages or $200). OAR 309-008-0100 et seq. (OHA behavioral health provider certification); residential SUD programs licensed under OAR 415-012. Enforced by the Oregon Attorney General and the Oregon Health Authority.","jurisdiction":"OR","status":"active","reviewed_date":"2026-07-23","review_interval_days":180,"status_detail":"","rule_counts":{"banned_claims":4,"required_disclaimers":1,"platform_policy_flags":0,"counsel_topics":0,"video_rules":0},"sources":[{"label":"ORS 646.608 (unlawful trade practices)","url":"https://oregon.public.law/statutes/ors_646.608","primary":true},{"label":"ORS 646.642 (civil penalties)","url":"https://oregon.public.law/statutes/ors_646.642","primary":true},{"label":"ORS 646.638 (private action)","url":"https://oregon.public.law/statutes/ors_646.638","primary":true},{"label":"OAR 309-008-0100 (OHA behavioral health certification)","url":"https://oregon.public.law/rules/oar_309-008-0100","primary":true}]},{"id":"state_survey_federal_only","title":"State SUD-marketing survey: federal-only jurisdictions (no distinctive state law)","authority":"Kesey 50-state substance-use-disorder marketing survey, conducted 2026-07-23. The states listed here were surveyed and found to have no distinctive SUD-specific marketing or patient-brokering statute beyond their general consumer-protection law. The applicable scanned layer for these states is federal: the FTC Act (15 U.S.C. 45) and the Opioid Addiction Recovery Fraud Prevention Act (15 U.S.C. 45d), plus HIPAA and platform rules where they apply. This ruleset adds no rules; it records the survey result and its scope so a scan in these states carries an explicit federal-only note.","jurisdiction":"US","status":"active","reviewed_date":"2026-07-23","review_interval_days":180,"status_detail":"FEDERAL-ONLY SCOPE PER THE 2026-07-23 STATE SURVEY","rule_counts":{"banned_claims":0,"required_disclaimers":0,"platform_policy_flags":0,"counsel_topics":0,"video_rules":0},"sources":[{"label":"FTC Act Section 5, 15 U.S.C. 45 (unfair or deceptive acts or practices)","url":"https://www.law.cornell.edu/uscode/text/15/45","primary":true},{"label":"Opioid Addiction Recovery Fraud Prevention Act of 2018, 15 U.S.C. 45d","url":"https://www.law.cornell.edu/uscode/text/15/45d","primary":true}]},{"id":"state_survey_verification_pending","title":"State SUD-marketing survey: verification-pending jurisdictions (law found, not yet modeled)","authority":"Kesey 50-state substance-use-disorder marketing survey, verification sweep 2026-07-23. Each state listed here was confirmed from primary sources to have a distinctive SUD-specific marketing or patient-brokering statute that Pre-Trip has NOT yet compiled into deterministic rules. This ruleset carries zero rules and stays pending so a scan in these states fails closed and surfaces the found citations for counsel review, rather than reading as clean federal-only coverage. It is retired per state as full rulesets are authored.","jurisdiction":"US","status":"pending_review","reviewed_date":null,"review_interval_days":90,"status_detail":"SUD-SPECIFIC STATE LAW FOUND 2026-07-23, NOT YET MODELED, FAILS CLOSED","rule_counts":{"banned_claims":0,"required_disclaimers":0,"platform_policy_flags":0,"counsel_topics":0,"video_rules":0},"sources":[{"label":"Kentucky KRS 222.429 (referral remuneration prohibition)","url":"https://apps.legislature.ky.gov/law/statutes/statute.aspx?id=54923","primary":true},{"label":"West Virginia Code 16-62-2 (Patient Brokering Act, prohibition and penalties)","url":"https://code.wvlegislature.gov/16-62-2/","primary":true},{"label":"Nevada NRS 458.112 (marketing of SUD treatment; prohibited activities)","url":"https://www.leg.state.nv.us/nrs/nrs-458.html","primary":true},{"label":"Washington RCW 71.24.037 (behavioral health agency standards; OUD/AUD advertising condition at (10))","url":"https://app.leg.wa.gov/rcw/default.aspx?cite=71.24.037","primary":true}]},{"id":"tennessee_addiction_marketing","title":"Tennessee prohibited addiction treatment marketing practices and provider referral kickbacks (TN)","authority":"Tenn. Code Ann. 33-2-423 (Prohibited Marketing Practices for alcohol and drug treatment: (a)(1) materially false or misleading representations about identity, products, services, or geographic locations; (a)(2) false website information, links, or redirection; (a)(3) soliciting or receiving a kickback or split-fee for a referral; (a)(4) contracting with a marketing provider that generates referrals or leads for patient placement through a call center or web-based presence, subject to a patient-disclosure exception) and Tenn. Code Ann. 63-1-159 (a Title 63 licensed healthcare provider may not knowingly offer, pay, solicit, receive, or aid and abet a commission, benefit, rebate, kickback, bribe, or split-fee to induce a referral to or from a Title 33, chapter 2, part 4 licensee or facility, as to alcohol and drug services under 33-2-402). Both enacted by Public Chapter 855, Acts of 2018 (HB2068), effective July 1 2018. Penalties reach license suspension or revocation under 33-2-407 and civil penalties under 33-2-409, plus license discipline and civil penalties for providers.","jurisdiction":"TN","status":"active","reviewed_date":"2026-07-23","review_interval_days":180,"status_detail":"","rule_counts":{"banned_claims":5,"required_disclaimers":1,"platform_policy_flags":0,"counsel_topics":0,"video_rules":0},"sources":[{"label":"Tenn. Code Ann. 33-2-423 (Prohibited Marketing Practices), enacted by Public Chapter 855, Acts of 2018 (HB2068), effective July 1 2018","url":"https://publications.tnsosfiles.com/acts/110/pub/pc0855.pdf","primary":true},{"label":"Tenn. Code Ann. 63-1-159 (provider referral kickback bar), enacted by Public Chapter 855, Acts of 2018 (HB2068), effective July 1 2018","url":"https://publications.tnsosfiles.com/acts/110/pub/pc0855.pdf","primary":true}]},{"id":"texas_ketamine","title":"Texas Medical Board advertising and FDA off-label drug marketing (physician-supervised care)","authority":"Texas Medical Board, 22 TAC Chapter 164 (esp. 164.3 Misleading or Deceptive Advertising, 164.4, 164.6). Federal: 21 U.S.C. 352, 21 CFR 201.128, 21 CFR 202.1.","jurisdiction":"TX","status":"active","reviewed_date":"2026-07-23","review_interval_days":90,"status_detail":"","rule_counts":{"banned_claims":8,"required_disclaimers":2,"platform_policy_flags":3,"counsel_topics":5,"video_rules":0},"sources":[{"label":"22 TAC Chapter 164 (TMB physician advertising, full text)","url":"https://apps.aaem.org/UserFiles/file/texas_medical_board_advertising_rules.pdf","primary":true},{"label":"22 TAC 164.3 (Misleading or Deceptive Advertising)","url":"http://txrules.elaws.us/rule/title22_chapter164_sec.164.3","primary":true},{"label":"21 U.S.C. 352 (misbranding)","url":"https://www.law.cornell.edu/uscode/text/21/352","primary":false},{"label":"21 CFR 201.128 (meaning of intended uses)","url":"https://www.law.cornell.edu/cfr/text/21/201.128","primary":false},{"label":"21 CFR 202.1 (prescription-drug advertising)","url":"https://www.law.cornell.edu/cfr/text/21/202.1","primary":false},{"label":"Meta Advertising Standards, Drugs and Pharmaceuticals","url":"https://transparency.meta.com/policies/ad-standards/restricted-goods-services/drugs-pharmaceuticals/","primary":true},{"label":"TMB Rule Changes (ketamine Ch. 173 proposed status)","url":"https://www.tmb.texas.gov/laws-rules/rule-changes","primary":true}]},{"id":"texas_treatment_marketing","title":"Texas Treatment Facilities Marketing Practices Act (TX)","authority":"Tex. Health and Safety Code ch. 164 (Treatment Facilities Marketing Practices Act), covering mental health and chemical dependency facilities. 164.010 marketing prohibitions; 164.005 solicitation compensation limits. Remedies: civil penalties of $1,000 to $25,000 per violation (164.011), private actions under the DTPA (164.013), and license discipline via the licensure cross-penalty (164.012). Enforced by the Texas Attorney General and licensing agencies.","jurisdiction":"TX","status":"active","reviewed_date":"2026-07-23","review_interval_days":180,"status_detail":"","rule_counts":{"banned_claims":4,"required_disclaimers":1,"platform_policy_flags":0,"counsel_topics":0,"video_rules":0},"sources":[{"label":"Tex. H&S Code ch. 164","url":"https://statutes.capitol.texas.gov/Docs/HS/htm/HS.164.htm","primary":true}]},{"id":"tx_dental","title":"Texas dental advertising (TSBDE + Dental Practice Act)","authority":"Texas State Board of Dental Examiners, 22 TAC Chapter 108 Subchapter E, Business Promotion (esp. 108.53 Fees, 108.54 Advertising of Specialties, 108.55 Advertising for General Dentists, 108.57 False, Misleading or Deceptive Advertising). Statute: Tex. Occ. Code Ch. 259 (esp. 259.005 Authorized Advertising Restrictions, 259.006 Unlawful Advertising in General).","jurisdiction":"TX","status":"pending_review","reviewed_date":null,"review_interval_days":180,"status_detail":"","rule_counts":{"banned_claims":7,"required_disclaimers":4,"platform_policy_flags":0,"counsel_topics":3,"video_rules":0},"sources":[{"label":"22 TAC 108.57 (False, Misleading or Deceptive Advertising)","url":"http://txrules.elaws.us/rule/title22_chapter108_sec.108.57","primary":true},{"label":"22 TAC 108.55 (Advertising for General Dentists)","url":"http://txrules.elaws.us/rule/title22_chapter108_sec.108.55","primary":true},{"label":"22 TAC 108.54 (Advertising of Specialties)","url":"http://txrules.elaws.us/rule/title22_chapter108_sec.108.54","primary":true},{"label":"22 TAC 108.53 (Fees)","url":"http://txrules.elaws.us/rule/title22_chapter108_sec.108.53","primary":true},{"label":"22 TAC Chapter 108 table of contents (Subchapter E, Business Promotion)","url":"http://txrules.elaws.us/rule/title22_chapter108","primary":true},{"label":"Tex. Occ. Code 259.005 (Authorized Advertising Restrictions)","url":"https://texas.public.law/statutes/tex._occ._code_section_259.005","primary":false},{"label":"Tex. Occ. Code 259.006 (Unlawful Advertising in General)","url":"https://texas.public.law/statutes/tex._occ._code_section_259.006","primary":false},{"label":"Tex. Occ. Code Chapter 259, official text (frame-rendered; text cross-checked via mirrors)","url":"https://statutes.capitol.texas.gov/Docs/OC/htm/OC.259.htm","primary":true},{"label":"22 Tex. Admin. Code 108.55 (Cornell LII cross-check)","url":"https://www.law.cornell.edu/regulations/texas/22-Tex-Admin-Code-SS-108-55","primary":false},{"label":"22 Tex. Admin. Code 108.54 (Cornell LII cross-check)","url":"https://www.law.cornell.edu/regulations/texas/22-Tex-Admin-Code-SS-108-54","primary":false}]},{"id":"utah_addiction_marketing","title":"Utah deceptive addiction treatment marketing (UT)","authority":"Utah patient-brokering law, Utah Code 26B-2-707 (current citation; recodified from the 2018 enactment at 62A-2-116, through an interim 26B-2-113, enacted by HB 14 and SB 222 in 2018), making it a class A misdemeanor to knowingly and willfully offer, pay, promise, solicit, or receive remuneration (a commission, bonus, kickback, bribe, or rebate), directly or indirectly, overtly or covertly, in cash or in kind, or to engage in a split-fee arrangement, in return for referring an individual for the furnishing or arranging of substance-use-disorder treatment; an information-service safe harbor at 26B-2-707(4)(e) exempts a non-steering service whose fees are set in advance, at fair market value, and not based on the potential value of a patient. Utah Consumer Sales Practices Act, Utah Code 13-11-4 (deceptive act or practice by a supplier; Title 13 was not part of the Title 26B recodification). Enforced through criminal prosecution for patient brokering and, under the Consumer Sales Practices Act, by the Utah Division of Consumer Protection and the Utah Attorney General.","jurisdiction":"UT","status":"active","reviewed_date":"2026-07-23","review_interval_days":180,"status_detail":"","rule_counts":{"banned_claims":4,"required_disclaimers":1,"platform_policy_flags":0,"counsel_topics":0,"video_rules":0},"sources":[{"label":"Utah Code 26B-2-707 (patient brokering; class A misdemeanor; information-service safe harbor at (4)(e)), current text","url":"https://le.utah.gov/xcode/Title26B/Chapter2/26B-2-S707.html","primary":true},{"label":"Utah Code 13-11-4 (Consumer Sales Practices Act, deceptive act or practice by a supplier)","url":"https://le.utah.gov/","primary":true}]}],"verticals":{"ketamine":"Ketamine clinic","psilocybin":"Psilocybin services","cannabis":"Cannabis","wellness_spa":"Wellness and med spa","dental":"Dental practice","aging":"Aging and longevity clinic","addiction_treatment":"Addiction treatment"},"asset_types":["email","landing_page","blog","social","video"],"states":["AK","AL","AR","AZ","CA","CO","CT","DC","DE","FL","GA","HI","IA","ID","IL","IN","KS","KY","LA","MA","MD","ME","MI","MN","MO","MS","MT","NC","ND","NE","NH","NJ","NM","NV","NY","OH","OK","OR","PA","RI","SC","SD","TN","TX","UT","VA","VT","WA","WI","WV","WY"],"state_coverage":{"AZ":{"state":"AZ","name":"Arizona","tier":"state","ruleset_id":"arizona_addiction_marketing","title":"Arizona addiction treatment patient brokering and sober living home marketing (AZ)","statutes":["A.R.S. 44-1522","A.R.S. 13-3730","A.R.S. 36-2062","A.R.S. 36-2063"],"reviewed_date":"2026-07-23","review_interval_days":90,"detail":"Live state pack. A.R.S. 44-1522; A.R.S. 13-3730; A.R.S. 36-2062. Reviewed 2026-07-23."},"CA":{"state":"CA","name":"California","tier":"state","ruleset_id":"california_addiction_marketing","title":"California deceptive addiction treatment marketing and patient brokering (CA)","statutes":["Cal. HSC 11831.6","Cal. HSC 11831.7","Cal. HSC 11831.9","Cal. Bus. and Prof. Code 17500","Cal. Bus. and Prof. Code 17200"],"reviewed_date":"2026-07-23","review_interval_days":180,"detail":"Live state pack. Cal. HSC 11831.6; Cal. HSC 11831.7; Cal. HSC 11831.9. Reviewed 2026-07-23."},"CO":{"state":"CO","name":"Colorado","tier":"state","ruleset_id":"co_nmha_dora","title":"Colorado Natural Medicine advertising (NMHA / DNM)","statutes":["1 CCR 213-1","4 CCR 755-1 Sec. 7 Advertising","C.R.S. 12-170-105","C.R.S. 44-50-203"],"reviewed_date":"2026-07-18","review_interval_days":120,"detail":"Live state pack. 1 CCR 213-1; 4 CCR 755-1 Sec. 7 Advertising; C.R.S. 12-170-105. Reviewed 2026-07-18."},"DE":{"state":"DE","name":"Delaware","tier":"state","ruleset_id":"delaware_addiction_marketing","title":"Delaware deceptive addiction treatment marketing (DE)","statutes":["6 Del. C. Chapter 25F, Patient Brokering","6 Del. C. 2513, Delaware Consumer Fraud Act"],"reviewed_date":"2026-07-23","review_interval_days":180,"detail":"Live state pack. 6 Del. C. Chapter 25F, Patient Brokering; 6 Del. C. 2513, Delaware Consumer Fraud Act. Reviewed 2026-07-23."},"FL":{"state":"FL","name":"Florida","tier":"state","ruleset_id":"florida_addiction_marketing","title":"Florida deceptive addiction treatment marketing and patient brokering (FL)","statutes":["Fla. Stat. 397.55","Fla. Stat. 817.505","Fla. Stat. 501.605"],"reviewed_date":"2026-07-23","review_interval_days":180,"detail":"Live state pack. Fla. Stat. 397.55; Fla. Stat. 817.505; Fla. Stat. 501.605. Reviewed 2026-07-23."},"GA":{"state":"GA","name":"Georgia","tier":"state","ruleset_id":"georgia_addiction_marketing","title":"Georgia deceptive addiction treatment marketing (GA)","statutes":["O.C.G.A. 26-5-80","O.C.G.A. 10-1-393","Georgia General Assembly SB 4"],"reviewed_date":"2026-07-23","review_interval_days":180,"detail":"Live state pack. O.C.G.A. 26-5-80; O.C.G.A. 10-1-393; Georgia General Assembly SB 4. Reviewed 2026-07-23."},"LA":{"state":"LA","name":"Louisiana","tier":"state","ruleset_id":"louisiana_addiction_marketing","title":"Louisiana addiction treatment marketing (LA)","statutes":["La. R.S. 14:70.5.1","La. R.S. 51:1405(A)"],"reviewed_date":"2026-07-23","review_interval_days":90,"detail":"Live state pack. La. R.S. 14:70.5.1; La. R.S. 51:1405(A). Reviewed 2026-07-23."},"NJ":{"state":"NJ","name":"New Jersey","tier":"state","ruleset_id":"new_jersey_addiction_marketing","title":"New Jersey addiction treatment patient brokering and deceptive marketing (NJ)","statutes":["N.J.S.A. 2C:40A-6","N.J.S.A. 56:8-230 to 56:8-232"],"reviewed_date":"2026-07-23","review_interval_days":120,"detail":"Live state pack. N.J.S.A. 2C:40A-6; N.J.S.A. 56:8-230 to 56:8-232. Reviewed 2026-07-23."},"NM":{"state":"NM","name":"New Mexico","tier":"state","ruleset_id":"new_mexico_addiction_marketing","title":"New Mexico deceptive addiction treatment marketing (NM)","statutes":["NMSA 57-12-2","NMSA 57-12-3","NMSA 57-12-10","NMSA 57-12-11"],"reviewed_date":"2026-07-23","review_interval_days":180,"detail":"Live state pack. NMSA 57-12-2; NMSA 57-12-3; NMSA 57-12-10. Reviewed 2026-07-23."},"NY":{"state":"NY","name":"New York","tier":"state","ruleset_id":"new_york_addiction_marketing","title":"New York deceptive addiction treatment marketing and patient brokering (NY)","statutes":["N.Y. Mental Hygiene Law 32.06","N.Y. Mental Hygiene Law 32.05","N.Y. Mental Hygiene Law 32.21","N.Y. General Business Law 349","N.Y. General Business Law 350"],"reviewed_date":"2026-07-23","review_interval_days":180,"detail":"Live state pack. N.Y. Mental Hygiene Law 32.06; N.Y. Mental Hygiene Law 32.05; N.Y. Mental Hygiene Law 32.21. Reviewed 2026-07-23."},"NC":{"state":"NC","name":"North Carolina","tier":"state","ruleset_id":"north_carolina_addiction_marketing","title":"North Carolina addiction treatment patient brokering and deceptive marketing (NC)","statutes":["N.C. Gen. Stat. Chapter 90, Article 5H"],"reviewed_date":"2026-07-23","review_interval_days":150,"detail":"Live state pack. N.C. Gen. Stat. Chapter 90, Article 5H. Reviewed 2026-07-23."},"OH":{"state":"OH","name":"Ohio","tier":"watch","ruleset_id":"ohio_addiction_marketing","title":"Ohio addiction treatment marketing (recovery-housing referral advisory; HB 58 watch)","statutes":[],"reviewed_date":"2026-07-23","review_interval_days":90,"detail":"Watch. One enacted advisory is live; pending legislation is documented but not compiled. Reviewed 2026-07-23."},"OR":{"state":"OR","name":"Oregon","tier":"state","ruleset_id":"oregon_addiction_marketing","title":"Oregon deceptive addiction treatment marketing (OR)","statutes":["ORS 646.608","ORS 646.642","ORS 646.638","OAR 309-008-0100"],"reviewed_date":"2026-07-23","review_interval_days":180,"detail":"Live state pack. ORS 646.608; ORS 646.642; ORS 646.638. Reviewed 2026-07-23."},"AL":{"state":"AL","name":"Alabama","tier":"federal_only","ruleset_id":"state_survey_federal_only","title":"State SUD-marketing survey: federal-only jurisdictions (no distinctive state law)","statutes":[],"reviewed_date":"2026-07-23","review_interval_days":180,"detail":"No distinctive state SUD-marketing statute as of the 2026-07-23 survey. The federal layer is scanned; general state consumer-protection law applies and is not scanned."},"AK":{"state":"AK","name":"Alaska","tier":"federal_only","ruleset_id":"state_survey_federal_only","title":"State SUD-marketing survey: federal-only jurisdictions (no distinctive state law)","statutes":[],"reviewed_date":"2026-07-23","review_interval_days":180,"detail":"No distinctive state SUD-marketing statute as of the 2026-07-23 survey. The federal layer is scanned; general state consumer-protection law applies and is not scanned."},"AR":{"state":"AR","name":"Arkansas","tier":"federal_only","ruleset_id":"state_survey_federal_only","title":"State SUD-marketing survey: federal-only jurisdictions (no distinctive state law)","statutes":[],"reviewed_date":"2026-07-23","review_interval_days":180,"detail":"No distinctive state SUD-marketing statute as of the 2026-07-23 survey. The federal layer is scanned; general state consumer-protection law applies and is not scanned."},"CT":{"state":"CT","name":"Connecticut","tier":"federal_only","ruleset_id":"state_survey_federal_only","title":"State SUD-marketing survey: federal-only jurisdictions (no distinctive state law)","statutes":[],"reviewed_date":"2026-07-23","review_interval_days":180,"detail":"No distinctive state SUD-marketing statute as of the 2026-07-23 survey. The federal layer is scanned; general state consumer-protection law applies and is not scanned."},"DC":{"state":"DC","name":"District of Columbia","tier":"federal_only","ruleset_id":"state_survey_federal_only","title":"State SUD-marketing survey: federal-only jurisdictions (no distinctive state law)","statutes":[],"reviewed_date":"2026-07-23","review_interval_days":180,"detail":"No distinctive state SUD-marketing statute as of the 2026-07-23 survey. The federal layer is scanned; general state consumer-protection law applies and is not scanned."},"HI":{"state":"HI","name":"Hawaii","tier":"federal_only","ruleset_id":"state_survey_federal_only","title":"State SUD-marketing survey: federal-only jurisdictions (no distinctive state law)","statutes":[],"reviewed_date":"2026-07-23","review_interval_days":180,"detail":"No distinctive state SUD-marketing statute as of the 2026-07-23 survey. The federal layer is scanned; general state consumer-protection law applies and is not scanned."},"ID":{"state":"ID","name":"Idaho","tier":"federal_only","ruleset_id":"state_survey_federal_only","title":"State SUD-marketing survey: federal-only jurisdictions (no distinctive state law)","statutes":[],"reviewed_date":"2026-07-23","review_interval_days":180,"detail":"No distinctive state SUD-marketing statute as of the 2026-07-23 survey. The federal layer is scanned; general state consumer-protection law applies and is not scanned."},"IL":{"state":"IL","name":"Illinois","tier":"federal_only","ruleset_id":"state_survey_federal_only","title":"State SUD-marketing survey: federal-only jurisdictions (no distinctive state law)","statutes":[],"reviewed_date":"2026-07-23","review_interval_days":180,"detail":"No distinctive state SUD-marketing statute as of the 2026-07-23 survey. The federal layer is scanned; general state consumer-protection law applies and is not scanned."},"IN":{"state":"IN","name":"Indiana","tier":"federal_only","ruleset_id":"state_survey_federal_only","title":"State SUD-marketing survey: federal-only jurisdictions (no distinctive state law)","statutes":[],"reviewed_date":"2026-07-23","review_interval_days":180,"detail":"No distinctive state SUD-marketing statute as of the 2026-07-23 survey. The federal layer is scanned; general state consumer-protection law applies and is not scanned."},"IA":{"state":"IA","name":"Iowa","tier":"federal_only","ruleset_id":"state_survey_federal_only","title":"State SUD-marketing survey: federal-only jurisdictions (no distinctive state law)","statutes":[],"reviewed_date":"2026-07-23","review_interval_days":180,"detail":"No distinctive state SUD-marketing statute as of the 2026-07-23 survey. The federal layer is scanned; general state consumer-protection law applies and is not scanned."},"KS":{"state":"KS","name":"Kansas","tier":"federal_only","ruleset_id":"state_survey_federal_only","title":"State SUD-marketing survey: federal-only jurisdictions (no distinctive state law)","statutes":[],"reviewed_date":"2026-07-23","review_interval_days":180,"detail":"No distinctive state SUD-marketing statute as of the 2026-07-23 survey. The federal layer is scanned; general state consumer-protection law applies and is not scanned."},"ME":{"state":"ME","name":"Maine","tier":"federal_only","ruleset_id":"state_survey_federal_only","title":"State SUD-marketing survey: federal-only jurisdictions (no distinctive state law)","statutes":[],"reviewed_date":"2026-07-23","review_interval_days":180,"detail":"No distinctive state SUD-marketing statute as of the 2026-07-23 survey. The federal layer is scanned; general state consumer-protection law applies and is not scanned."},"MD":{"state":"MD","name":"Maryland","tier":"federal_only","ruleset_id":"state_survey_federal_only","title":"State SUD-marketing survey: federal-only jurisdictions (no distinctive state law)","statutes":[],"reviewed_date":"2026-07-23","review_interval_days":180,"detail":"No distinctive state SUD-marketing statute as of the 2026-07-23 survey. The federal layer is scanned; general state consumer-protection law applies and is not scanned."},"MA":{"state":"MA","name":"Massachusetts","tier":"federal_only","ruleset_id":"state_survey_federal_only","title":"State SUD-marketing survey: federal-only jurisdictions (no distinctive state law)","statutes":[],"reviewed_date":"2026-07-23","review_interval_days":180,"detail":"No distinctive state SUD-marketing statute as of the 2026-07-23 survey. The federal layer is scanned; general state consumer-protection law applies and is not scanned."},"MI":{"state":"MI","name":"Michigan","tier":"federal_only","ruleset_id":"state_survey_federal_only","title":"State SUD-marketing survey: federal-only jurisdictions (no distinctive state law)","statutes":[],"reviewed_date":"2026-07-23","review_interval_days":180,"detail":"No distinctive state SUD-marketing statute as of the 2026-07-23 survey. The federal layer is scanned; general state consumer-protection law applies and is not scanned."},"MN":{"state":"MN","name":"Minnesota","tier":"federal_only","ruleset_id":"state_survey_federal_only","title":"State SUD-marketing survey: federal-only jurisdictions (no distinctive state law)","statutes":[],"reviewed_date":"2026-07-23","review_interval_days":180,"detail":"No distinctive state SUD-marketing statute as of the 2026-07-23 survey. The federal layer is scanned; general state consumer-protection law applies and is not scanned."},"MS":{"state":"MS","name":"Mississippi","tier":"federal_only","ruleset_id":"state_survey_federal_only","title":"State SUD-marketing survey: federal-only jurisdictions (no distinctive state law)","statutes":[],"reviewed_date":"2026-07-23","review_interval_days":180,"detail":"No distinctive state SUD-marketing statute as of the 2026-07-23 survey. The federal layer is scanned; general state consumer-protection law applies and is not scanned."},"MO":{"state":"MO","name":"Missouri","tier":"federal_only","ruleset_id":"state_survey_federal_only","title":"State SUD-marketing survey: federal-only jurisdictions (no distinctive state law)","statutes":[],"reviewed_date":"2026-07-23","review_interval_days":180,"detail":"No distinctive state SUD-marketing statute as of the 2026-07-23 survey. The federal layer is scanned; general state consumer-protection law applies and is not scanned."},"MT":{"state":"MT","name":"Montana","tier":"federal_only","ruleset_id":"state_survey_federal_only","title":"State SUD-marketing survey: federal-only jurisdictions (no distinctive state law)","statutes":[],"reviewed_date":"2026-07-23","review_interval_days":180,"detail":"No distinctive state SUD-marketing statute as of the 2026-07-23 survey. The federal layer is scanned; general state consumer-protection law applies and is not scanned."},"NE":{"state":"NE","name":"Nebraska","tier":"federal_only","ruleset_id":"state_survey_federal_only","title":"State SUD-marketing survey: federal-only jurisdictions (no distinctive state law)","statutes":[],"reviewed_date":"2026-07-23","review_interval_days":180,"detail":"No distinctive state SUD-marketing statute as of the 2026-07-23 survey. The federal layer is scanned; general state consumer-protection law applies and is not scanned."},"NH":{"state":"NH","name":"New Hampshire","tier":"federal_only","ruleset_id":"state_survey_federal_only","title":"State SUD-marketing survey: federal-only jurisdictions (no distinctive state law)","statutes":[],"reviewed_date":"2026-07-23","review_interval_days":180,"detail":"No distinctive state SUD-marketing statute as of the 2026-07-23 survey. The federal layer is scanned; general state consumer-protection law applies and is not scanned."},"ND":{"state":"ND","name":"North Dakota","tier":"federal_only","ruleset_id":"state_survey_federal_only","title":"State SUD-marketing survey: federal-only jurisdictions (no distinctive state law)","statutes":[],"reviewed_date":"2026-07-23","review_interval_days":180,"detail":"No distinctive state SUD-marketing statute as of the 2026-07-23 survey. The federal layer is scanned; general state consumer-protection law applies and is not scanned."},"OK":{"state":"OK","name":"Oklahoma","tier":"federal_only","ruleset_id":"state_survey_federal_only","title":"State SUD-marketing survey: federal-only jurisdictions (no distinctive state law)","statutes":[],"reviewed_date":"2026-07-23","review_interval_days":180,"detail":"No distinctive state SUD-marketing statute as of the 2026-07-23 survey. The federal layer is scanned; general state consumer-protection law applies and is not scanned."},"PA":{"state":"PA","name":"Pennsylvania","tier":"federal_only","ruleset_id":"state_survey_federal_only","title":"State SUD-marketing survey: federal-only jurisdictions (no distinctive state law)","statutes":[],"reviewed_date":"2026-07-23","review_interval_days":180,"detail":"No distinctive state SUD-marketing statute as of the 2026-07-23 survey. The federal layer is scanned; general state consumer-protection law applies and is not scanned."},"RI":{"state":"RI","name":"Rhode Island","tier":"federal_only","ruleset_id":"state_survey_federal_only","title":"State SUD-marketing survey: federal-only jurisdictions (no distinctive state law)","statutes":[],"reviewed_date":"2026-07-23","review_interval_days":180,"detail":"No distinctive state SUD-marketing statute as of the 2026-07-23 survey. The federal layer is scanned; general state consumer-protection law applies and is not scanned."},"SC":{"state":"SC","name":"South Carolina","tier":"federal_only","ruleset_id":"state_survey_federal_only","title":"State SUD-marketing survey: federal-only jurisdictions (no distinctive state law)","statutes":[],"reviewed_date":"2026-07-23","review_interval_days":180,"detail":"No distinctive state SUD-marketing statute as of the 2026-07-23 survey. The federal layer is scanned; general state consumer-protection law applies and is not scanned."},"SD":{"state":"SD","name":"South Dakota","tier":"federal_only","ruleset_id":"state_survey_federal_only","title":"State SUD-marketing survey: federal-only jurisdictions (no distinctive state law)","statutes":[],"reviewed_date":"2026-07-23","review_interval_days":180,"detail":"No distinctive state SUD-marketing statute as of the 2026-07-23 survey. The federal layer is scanned; general state consumer-protection law applies and is not scanned."},"VT":{"state":"VT","name":"Vermont","tier":"federal_only","ruleset_id":"state_survey_federal_only","title":"State SUD-marketing survey: federal-only jurisdictions (no distinctive state law)","statutes":[],"reviewed_date":"2026-07-23","review_interval_days":180,"detail":"No distinctive state SUD-marketing statute as of the 2026-07-23 survey. The federal layer is scanned; general state consumer-protection law applies and is not scanned."},"VA":{"state":"VA","name":"Virginia","tier":"federal_only","ruleset_id":"state_survey_federal_only","title":"State SUD-marketing survey: federal-only jurisdictions (no distinctive state law)","statutes":[],"reviewed_date":"2026-07-23","review_interval_days":180,"detail":"No distinctive state SUD-marketing statute as of the 2026-07-23 survey. The federal layer is scanned; general state consumer-protection law applies and is not scanned."},"WI":{"state":"WI","name":"Wisconsin","tier":"federal_only","ruleset_id":"state_survey_federal_only","title":"State SUD-marketing survey: federal-only jurisdictions (no distinctive state law)","statutes":[],"reviewed_date":"2026-07-23","review_interval_days":180,"detail":"No distinctive state SUD-marketing statute as of the 2026-07-23 survey. The federal layer is scanned; general state consumer-protection law applies and is not scanned."},"WY":{"state":"WY","name":"Wyoming","tier":"federal_only","ruleset_id":"state_survey_federal_only","title":"State SUD-marketing survey: federal-only jurisdictions (no distinctive state law)","statutes":[],"reviewed_date":"2026-07-23","review_interval_days":180,"detail":"No distinctive state SUD-marketing statute as of the 2026-07-23 survey. The federal layer is scanned; general state consumer-protection law applies and is not scanned."},"KY":{"state":"KY","name":"Kentucky","tier":"verification_pending","ruleset_id":"state_survey_verification_pending","title":"State SUD-marketing survey: verification-pending jurisdictions (law found, not yet modeled)","statutes":["Kentucky KRS 222.429","West Virginia Code 16-62-2","Nevada NRS 458.112","Washington RCW 71.24.037"],"reviewed_date":null,"review_interval_days":90,"detail":"State SUD-marketing law found in the 2026-07-23 sweep but not yet modeled: Kentucky KRS 222.429; West Virginia Code 16-62-2; Nevada NRS 458.112; Washington RCW 71.24.037. Scans fail closed here; take copy to counsel."},"WV":{"state":"WV","name":"West Virginia","tier":"verification_pending","ruleset_id":"state_survey_verification_pending","title":"State SUD-marketing survey: verification-pending jurisdictions (law found, not yet modeled)","statutes":["Kentucky KRS 222.429","West Virginia Code 16-62-2","Nevada NRS 458.112","Washington RCW 71.24.037"],"reviewed_date":null,"review_interval_days":90,"detail":"State SUD-marketing law found in the 2026-07-23 sweep but not yet modeled: Kentucky KRS 222.429; West Virginia Code 16-62-2; Nevada NRS 458.112; Washington RCW 71.24.037. Scans fail closed here; take copy to counsel."},"NV":{"state":"NV","name":"Nevada","tier":"verification_pending","ruleset_id":"state_survey_verification_pending","title":"State SUD-marketing survey: verification-pending jurisdictions (law found, not yet modeled)","statutes":["Kentucky KRS 222.429","West Virginia Code 16-62-2","Nevada NRS 458.112","Washington RCW 71.24.037"],"reviewed_date":null,"review_interval_days":90,"detail":"State SUD-marketing law found in the 2026-07-23 sweep but not yet modeled: Kentucky KRS 222.429; West Virginia Code 16-62-2; Nevada NRS 458.112; Washington RCW 71.24.037. Scans fail closed here; take copy to counsel."},"WA":{"state":"WA","name":"Washington","tier":"verification_pending","ruleset_id":"state_survey_verification_pending","title":"State SUD-marketing survey: verification-pending jurisdictions (law found, not yet modeled)","statutes":["Kentucky KRS 222.429","West Virginia Code 16-62-2","Nevada NRS 458.112","Washington RCW 71.24.037"],"reviewed_date":null,"review_interval_days":90,"detail":"State SUD-marketing law found in the 2026-07-23 sweep but not yet modeled: Kentucky KRS 222.429; West Virginia Code 16-62-2; Nevada NRS 458.112; Washington RCW 71.24.037. Scans fail closed here; take copy to counsel."},"TN":{"state":"TN","name":"Tennessee","tier":"state","ruleset_id":"tennessee_addiction_marketing","title":"Tennessee prohibited addiction treatment marketing practices and provider referral kickbacks (TN)","statutes":["Tenn. Code Ann. 33-2-423","Tenn. Code Ann. 63-1-159"],"reviewed_date":"2026-07-23","review_interval_days":180,"detail":"Live state pack. Tenn. Code Ann. 33-2-423; Tenn. Code Ann. 63-1-159. Reviewed 2026-07-23."},"TX":{"state":"TX","name":"Texas","tier":"state","ruleset_id":"texas_ketamine","title":"Texas Medical Board advertising and FDA off-label drug marketing (physician-supervised care)","statutes":["22 TAC Chapter 164","22 TAC 164.3","Meta Advertising Standards, Drugs and Pharmaceuticals","TMB Rule Changes"],"reviewed_date":"2026-07-23","review_interval_days":90,"detail":"Live state pack. 22 TAC Chapter 164; 22 TAC 164.3; Meta Advertising Standards, Drugs and Pharmaceuticals. Reviewed 2026-07-23."},"UT":{"state":"UT","name":"Utah","tier":"state","ruleset_id":"utah_addiction_marketing","title":"Utah deceptive addiction treatment marketing (UT)","statutes":["Utah Code 26B-2-707","Utah Code 13-11-4"],"reviewed_date":"2026-07-23","review_interval_days":180,"detail":"Live state pack. Utah Code 26B-2-707; Utah Code 13-11-4. Reviewed 2026-07-23."}},"pricing":{"currency":"usd","free_trial":{"scans_per_asset_type":1,"label":"First check is on us","blurb":"One free scan of each asset type: an email, a landing page, a blog post, and a social post."},"token_packs":[{"key":"pack_10","label":"10 tokens","tokens":10,"price_cents":1900,"blurb":"Pay as you go. One token, one scan, any asset type. Tokens never expire."},{"key":"pack_50","label":"50 tokens","tokens":50,"price_cents":8900,"blurb":"The working-agency pack, 6 percent off the single rate. Tokens never expire."},{"key":"pack_100","label":"100 tokens","tokens":100,"price_cents":16900,"blurb":"Stock the shelf, 11 percent off the single rate. Tokens never expire."}],"bus_passes":[{"key":"bus_pass_100","label":"Bus Pass 100","scans_per_period":100,"period":"month","price_cents":15900,"blurb":"A seat on the bus: up to 100 scans a month, every ruleset, cancel anytime. Unused scans do not roll over."},{"key":"bus_pass_250","label":"Bus Pass 250","scans_per_period":250,"period":"month","price_cents":34900,"blurb":"The busy-desk pass: up to 250 scans a month at 26 percent off the single rate. Cancel anytime."},{"key":"bus_pass_500","label":"Bus Pass 500","scans_per_period":1500,"period":"quarter","price_cents":179700,"blurb":"The agency workhorse: 500 scans a month pooled across the quarter, billed every 3 months. Heavy campaign months can borrow from quiet ones."}],"video":{"tokens_per_started_30s":1,"min_tokens":2,"max_seconds":180,"blurb":"Video creatives cost 1 token per started 30 seconds, 2 token minimum, priced before you confirm. Time-coded findings, same rulesets, plus the video disclosure pack."}}}